Patents by Inventor Luc Mouthon

Luc Mouthon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150323550
    Abstract: The invention relates to an in vitro method for detecting systemic scleroderma (SSc) and/or pulmonary arterial hypertension (PAH), or a risk of developing SSc or PAH, which comprises determining the presence and/or the amount of antibodies in a biological sample originating from a patient.
    Type: Application
    Filed: April 14, 2015
    Publication date: November 12, 2015
    Inventors: Luc MOUTHON, Marc HUMBERT, Cynthia CALZAS, Luc CAMOIN, Younes SAHBATOU
  • Patent number: 8609356
    Abstract: The invention relates to an in vitro method for detecting pulmonary arterial hypertension (PAHT), or the risk of developing PAHT, which includes determining the presence and/or amount of anti-tenascin C antibodies in a biological sample from a patient.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: December 17, 2013
    Assignees: Assistance Publique-Hopitaux de Paris, Universite Paris Descartes, Universite Paris-Sud 11
    Inventors: Luc Mouthon, Marc Humbert, Mathieu Tamby
  • Publication number: 20120088257
    Abstract: The invention relates to a method for the in vitro detection of vasculitis or the risk of developing vasculitis, including determining the presence and/or the amount of anti-endothelial cell antibodies (AECA) or anti-vascular smooth muscle cell (VSMC) antibodies in a biological sample from a patient.
    Type: Application
    Filed: February 25, 2010
    Publication date: April 12, 2012
    Applicant: Assistance Publique - Hopitaux de Paris
    Inventors: Luc Mouthon, Hanadi Dib, Alexis Regent
  • Publication number: 20110311995
    Abstract: The invention relates to an in vitro method for detecting systemic scleroderma (SSc) and/or pulmonary arterial hypertension (PAH), or a risk of developing SSc or PAH, which comprises determining the presence and/or the amount of antibodies in a biological sample originating from a patient.
    Type: Application
    Filed: September 17, 2009
    Publication date: December 22, 2011
    Inventors: Luc Mouthon, Marc Humbert, Cynthia Calzas, Luc Camoin, Younes Sahbatou
  • Publication number: 20110033876
    Abstract: The invention relates to an in vitro method for detecting pulmonary arterial hypertension (PAHT), or the risk of developing PAHT, which includes determining the presence and/or amount of anti-tenascin C antibodies in a biological sample from a patient.
    Type: Application
    Filed: April 10, 2009
    Publication date: February 10, 2011
    Applicant: UNIVERSITE PARIS-SUD 11
    Inventors: Luc Mouthon, Marc Humbert, Mathieu Tamby